Abstract:Objective: Idiopathic osteoarthritis is the most common form of osteoarthritis (OA) world-wide and remains the leading cause of disability and the associated socio-economic burden in an increasing aging population. Traditionally, OA has been viewed as a degenerative joint disease characterized by progressive destruction of the articular cartilage and changes in the subchondral bone culminating in joint failure. However, the etiology of OA is multifactorial involving genetic, mechanical and environmental factors. Treatment modalities include analgesia, joint injection with steroids or hyaluronic acid, oral supplements including glucosamine and chondroitin sulfate, as well as physiotherapy. Thus, there is significant interest in the discovery of disease modifying agents. One such agent, glucosamine (GlcN) is commonly prescribed even though the therapeutic efficacy and mechanism of action remain controversial. Inflammatory cytokines, including IL-1 beta, and proteinases such as MMP-13 have been implicated in the pathogenesis and progression of OA together with an associated CpG demethylation in their promoters. We have investigated the potential of GlcN to modulate NF-kB activity and cytokine-induced abnormal gene expression in articular chondrocytes and, critically, whether this is associated with an epigenetic process. Method: Human chondrocytes were isolated from the articular cartilage of femoral heads, obtained with ethical permission, following fractured neck of femur surgery. Chondrocytes were cultured for 5 weeks in six separate groups; (i) control culture, (ii) cultured with a mixture of 2.5 ng/ml IL-1 beta and 2.5 ng/ml oncostatin M (OSM), (iii) cultured with 2 mM N-acetyl GlcN (Sigma-Aldrich), (iv) cultured with a mixture of 2.5 ng/ml IL-1 beta, 2.5 ng/ml OSM and 2 mM GlcN, (v) cultured with 1.0 mu M BAY 11-7082 (BAY; NF-kB inhibitor: Calbiochem, Darmstadt, Germany) and, (vi) cultured with a mixture of 2.5 ng/ml IL-1 beta, 2.5 ng/ml OSM and 1.0 mu M BAY. The levels of IL1B and MMP13 mRNA were examined using qRT-PCR. The percentage DNA methylation in the CpG sites of the IL1 beta and MMP13 proximal promoter were quantified by pyrosequencing. Result: IL1 beta expression was enhanced over 580-fold in articular chondrocytes treated with IL-1 beta and OSM. GlcN dramatically ameliorated the cytokine-induced expression by 4-fold. BAY alone increased IL1 beta expression by 3-fold. In the presence of BAY, IL-1 beta induced IL1B mRNA levels were decreased by 6-fold. The observed average percentage methylation of the -256 CpG site in the IL1 beta promoter was 65% in control cultures and decreased to 36% in the presence of IL-1 beta/OSM. GlcN and BAY alone had a negligible effect on the methylation status of the IL1B promoter. The cytokine-induced loss of methylation status in the IL1B promoter was ameliorated by both GlcN and BAY to 44% and 53%, respectively. IL-1 beta/OSM treatment increased MMP13 mRNA levels independently of either GlcN or BAY and no change in the methylation status of the MMP13 promoter was observed. Conclusion: We demonstrate for the first time that GlcN and BAY can prevent cytokine-induced demethylation of a specific CpG site in the IL1 beta promoter and this was associated with decreased expression of IL1 beta. These studies provide a potential mechanism of action for OA disease modifying agents via NF-kB and, critically, demonstrate the need for further studies to elucidate the role that NF-kB may play in DNA demethylation in human chondrocytes. (C) 2011 Elsevier Inc. All rights reserved.

Acetaminophen changes the RNA m 6 A levels and m 6 A-related proteins expression in IL-1β-treated chondrocyte cells

Acetaminophen changes the RNA m<SUP>6</SUP>A levels and m<SUP>6</SUP>A-related proteins expression in IL-1-treated chondrocyte cells

Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1β-treated chondrocyte cells

Acacetin inhibits expression of matrix metalloproteinases via a MAPK-dependent mechanism in fibroblast-like synoviocytes.

The Epigenetic Effect of Glucosamine and A Nuclear Factor-Kappa B (Nf-Kb) Inhibitor on Primary Human Chondrocytes - Implications for Osteoarthritis

OC01: INFLAMMATORY CYTOKINES CAUSE LOSS OF DNA METHYLATION TOGETHER WITH INDUCTION OF ABNORMAL GENE EXPRESSION IN HEALTHY HUMAN ARTICULAR CHONDROCYTES

Anti-arthritic effects of chlorogenic acid in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.

Bornyl acetate has an anti-inflammatory effect in human chondrocytes via induction of IL-11.

Cordycepin Modulates Inflammatory and Catabolic Gene Expression in Interleukin-1Beta-induced Human Chondrocytes from Advanced-Stage Osteoarthritis: an in Vitro Study.

Identification of Chondrocyte Genes and Signaling Pathways in Response to Acute Joint Inflammation

Effect of alendronate sodium on chondrocytes in joint inflammation through down-regulation of microRNA-184 (miR-184)

Inflammatory Microenvironment Promotes Extracellular Matrix Degradation of Chondrocytes Through ALKBH5-dependent Runx2 M6a Modification in the Pathogenesis of Osteoarthritis

Acetaminophen reduces osteoprotegerin synthesis stimulated by PGE2 and PGF2α in osteoblasts: attenuation of SAPK/JNK but not p38 MAPK or p44/p42 MAPK

The Annexin A1 Protein Mimetic Peptide Ac2-26 Prevents Cellular Senescence of CHON-001 Chondrocytes Against Tumor Necrosis Factor-Α Via the Nrf2/NF-κB Pathway.

Avicularin Suppresses Cartilage Extracellular Matrix Degradation and Inflammation Via TRAF6/MAPK Activation

Chelidonine reduces IL-1β-induced inflammation and matrix catabolism in chondrocytes and attenuates cartilage degeneration and synovial inflammation in rats

Interleukin 1β and lipopolysaccharides induction dictate chondrocyte morphological properties and reduce cellular roughness and adhesion energy comparatively

Effect of puerarin on TIMP 3 , MMP-9 expression and methylation in chondrocytes of rat osteoarthritis

Effect of chitosan/pCDNA3.1 (+) CrmA on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expressions of chondrocytes induced by interleukin-1β

Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification

Interleukin-6 Synthesis in Human Chondrocytes is Regulated Via the Antagonistic Actions of Prostaglandin (PG)E2 and 15-Deoxy-δ12,14-pgj2